Aviceda Therapeutics
MA - Cambridge
BiotechnologyFocus: Next generation of glyco-immune therapeutics
Aviceda Therapeutics is a life sciences company focused on Next generation of glyco-immune therapeutics.
Funding Stage
PUBLIC
Employees
1-50
Total Funding
$100M
Open Jobs
0
Pipeline & Clinical Trials
AVD-104
Diabetic Macular EdemaClinical Trials (1)
NCT06181227A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema
Phase 2Phase 2
Clinical Trials (1)
NCT05839041A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2000
Portfolio: 2 clinical trials
Hiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles